RYAN STRASSER: Open Payments
NPI 1962016394 · STRATHAM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,181 in 233 payments from 18 companies in 2025. Trend: 2023 $5,024 · 2024 $5,115 · 2025 $4,181
Food & beverage: $4,030Education: $151
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $861 |
| ABBVIE INC. | 29 | $508 |
| GENZYME CORPORATION | 11 | $361 |
| Novartis Pharmaceuticals Corporation | 13 | $287 |
| E.R. Squibb & Sons, L.L.C. | 17 | $282 |
| Organon LLC | 17 | $281 |
| Lilly USA, LLC | 12 | $247 |
| Galderma Laboratories, L.P. | 20 | $225 |
| UCB, Inc. | 11 | $221 |
| Arcutis Biotherapeutics, Inc. | 18 | $220 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Sotyktu, TALTZ, Bimzelx, Zoryve, NEMLUVIO.
Industry payments across NH — which companies pay providers there.
